|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
RGEN | DAWES KAREN A | Director | Feb 27 | Option Exercise | 42.07 | 4,626 | 194,616 | 88,367 | Feb 28 09:56 PM |
RGEN | DAWES KAREN A | Director | Feb 27 | Sale | 193.35 | 1,000 | 193,350 | 87,367 | Feb 28 09:56 PM |
RGEN | DAWES KAREN A | Director | Aug 29 | Option Exercise | 18.12 | 7,392 | 133,943 | 84,591 | Aug 30 04:06 PM |
RGEN | DAWES KAREN A | Director | Aug 29 | Sale | 171.38 | 850 | 145,673 | 83,741 | Aug 30 04:06 PM |
RGEN | DAWES KAREN A | Director | Sep 09 | Sale | 227.17 | 775 | 176,057 | 76,401 | Sep 09 04:14 PM |
RGEN | DAWES KAREN A | Director | May 25 | Sale | 150.51 | 14,715 | 2,214,819 | 76,532 | May 26 05:17 PM |
RGEN | DAWES KAREN A | Director | Nov 10 | Sale | 263.93 | 4,783 | 1,262,355 | 91,247 | Nov 12 05:12 PM |
RGEN | DAWES KAREN A | Director | Nov 02 | Sale | 303.94 | 2,400 | 729,467 | 91,247 | Nov 04 05:41 PM |
RGEN | DAWES KAREN A | Director | Sep 14 | Sale | 294.26 | 274 | 80,628 | 93,647 | Sep 15 05:46 PM |
RGEN | DAWES KAREN A | Director | Sep 01 | Sale | 283.91 | 3,459 | 982,058 | 93,921 | Sep 02 04:29 PM |
RGEN | DAWES KAREN A | Director | Aug 17 | Sale | 253.77 | 17,514 | 4,444,561 | 95,363 | Aug 19 04:42 PM |
RGEN | DAWES KAREN A | Director | Aug 18 | Sale | 259.03 | 1,402 | 363,166 | 93,961 | Aug 19 04:42 PM |
RGEN | DAWES KAREN A | Director | Jul 20 | Sale | 202.09 | 4,585 | 926,605 | 112,877 | Jul 22 08:25 PM |
RGEN | DAWES KAREN A | Director | Jul 13 | Option Exercise | 41.19 | 2,929 | 120,646 | 118,982 | Jul 15 05:17 PM |
RGEN | DAWES KAREN A | Director | May 11 | Option Exercise | 3.22 | 15,000 | 48,300 | 115,734 | May 13 05:01 PM |
RGEN | DAWES KAREN A | Director | May 11 | Sale | 176.85 | 285 | 50,402 | 115,449 | May 13 05:01 PM |
BRNS | DAWES KAREN A | Director | May 04 | Buy | 17.00 | 1,700 | 28,900 | 1,700 | May 06 04:29 PM |
RGEN | DAWES KAREN A | Director | Jun 18 | Sale | 115.20 | 18,705 | 2,154,851 | 100,734 | Jun 22 04:42 PM |
RGEN | DAWES KAREN A | Director | May 20 | Sale | 139.44 | 517 | 72,093 | 119,439 | May 21 09:08 PM |
RGEN | DAWES KAREN A | Director | May 18 | Sale | 137.78 | 1,600 | 220,448 | 119,956 | May 19 08:46 PM |
ASRT | DAWES KAREN A | Director | May 08 | Sale | 0.79 | 15,834 | 12,531 | 84,589 | May 11 08:23 PM |
RGEN | DAWES KAREN A | Director | Apr 21 | Option Exercise | 3.30 | 11,800 | 38,940 | 120,834 | Apr 22 06:07 PM |
RGEN | DAWES KAREN A | Director | Apr 20 | Option Exercise | 3.30 | 8,200 | 27,060 | 121,234 | Apr 22 06:07 PM |
RGEN | DAWES KAREN A | Director | Apr 20 | Sale | 104.57 | 12,200 | 1,275,717 | 109,034 | Apr 22 06:07 PM |
RGEN | DAWES KAREN A | Director | Feb 21 | Sale | 98.70 | 4,000 | 394,793 | 113,034 | Feb 24 05:51 PM |
RGEN | DAWES KAREN A | Director | Jun 17 | Option Exercise | 4.96 | 20,000 | 99,200 | 118,329 | Jun 19 07:00 PM |
RGEN | DAWES KAREN A | Director | Jun 17 | Sale | 77.35 | 1,295 | 100,168 | 117,034 | Jun 19 07:00 PM |
RGEN | DAWES KAREN A | Director | May 11 | Option Exercise | 5.08 | 20,000 | 101,600 | 114,957 | May 15 09:53 AM |
RGEN | DAWES KAREN A | Director | May 11 | Sale | 41.80 | 20,000 | 835,936 | 94,957 | May 15 09:53 AM |
RGEN | DAWES KAREN A | Director | Mar 21 | Option Exercise | 4.29 | 20,000 | 85,800 | 95,764 | Mar 22 05:20 PM |
RGEN | DAWES KAREN A | Director | Mar 21 | Sale | 34.12 | 2,521 | 86,017 | 93,243 | Mar 22 05:20 PM |
RGEN | DAWES KAREN A | Director | Jun 27 | Option Exercise | 3.10 | 15,000 | 46,500 | 57,746 | Jun 28 04:40 PM |
RGEN | DAWES KAREN A | Director | Jun 21 | Buy | 7.70 | 1,000 | 7,700 | 33,880 | Jun 21 02:16 PM |
RGEN | DAWES KAREN A | Director | Aug 12 | Buy | 3.49 | 10,000 | 34,946 | 150,500 | Aug 15 09:02 AM |
RGEN | DAWES KAREN A | Director | Jun 14 | Buy | 3.57 | 4,500 | 16,084 | 6,500 | Jun 15 03:01 PM |
RGEN | DAWES KAREN A | Director | Dec 01 | Buy | 3.50 | 2,000 | 7,000 | 50,000 | Dec 03 05:32 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite